Diagnostic performance of bone scintigraphy and 11C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer

被引:15
|
作者
Garcia, J. R. [1 ]
Moreno, C. [1 ]
Valls, E. [1 ]
Cozar, P. [1 ]
Bassa, P. [1 ]
Soler, M. [1 ]
Alvarez-Moro, F. J. [1 ]
Moragas, M. [1 ]
Riera, E. [1 ]
机构
[1] Unidad PET CETIR ERESA, Barcelona, Spain
关键词
Bone scintigraphy; C-11-Choline PET/CT; Bone metastases; Biochemical recurrence; Prostate cancer; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; F-18-FLUORIDE PET; F-18-FDG PET/CT; DISEASE; SPECT; ONCOLOGY; RELAPSE; CT;
D O I
10.1016/j.remn.2014.08.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To compare bone scan (BS) with C-11-Choline PET/CT for the detection of bone metastases in patients with biochemical recurrence of prostate cancer (PC). Material and Methods: A total of 169 patients with biochemical recurrence of PC(PSA:2.4-58 ng/ml) who were referred for both exams (0-15 days-in-between) were included. Lesion-detection-rate per patients and lesions were analyzed for both BS and C-11-Choline PET/CT. Metastasis diagnosis was reached by: biopsy, CT/F-18-Fluoride PET/MRI confirmation, or evidence of progression in subsequent imaging procedures. Results: A total of 91 lesions were found to be active in BS and/or C-11-choline PET/CT (40 patients), with 78 of which were metastatic. BS detected 38 blastic, 2 lytic and 10 non-CT-evident lesions. C-11-Choline PET/CT detected 41 blastic, 4 lytic and 29 non-CT-evident lesions. BS and C-11-Choline PET/CT sensitivities were 65.4% and 96.1%; specificities ere 38.5 and 92.3% (chi(2) 8.27, p < 0.04). Both imaging techniques were negative in 118 patients. Tracer avid lesions were found in 51 patients: with 30/51 being BS and C-11-Choline PET/CT concordant; in 21/51 patients had discordant lesions (kappa 0.712, p = 0.00). Lesions were absolutely discordant in 10/19 patients,: 5 FN BS, 2 FP BS (degenerative changes: dysplasia), 1 FN C-11-Choline PET/CT (blastic), 1 FP C-11-Choline PET/CT (degenerative), 1 out of field-of-view lesion with C-11-Choline PET/CT (tibia alone). C-11-Choline PET/CT showed extraosseous involvement in 26/51 patients with bone metastases: 9 local recurrences, 5 infra-diaphragmatic-lymph-nodes, 2 supra-diaphragmatic, 5 local and infra-diaphragmatic, 4 infra- and supra-diaphragmatic, 1 supra-diaphragmatic and lung metastases. Conclusion: C-11-Choline PET/CT yielded better sensitivity and specificity than BS for the detection of bone involvement in patients with biochemical recurrence of PC and allowed extraosseous restaging, with an impact in the clinical management of these patients. (C) 2014 Elsevier Espana, S.L.U. and SEMNIM. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [41] Clinical application of 11C-Choline PET in patients with biochemical relapse of prostate cancer
    Malinverni, G.
    Landoni, C.
    Stasi, M.
    Picchio, M.
    Gatti, M.
    Delmastro, E.
    Bona, C.
    Gabriele, P.
    Fazio, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 318 - 318
  • [42] Low diagnostic yield of the 11C-choline PET/CT in the detection of liver metastasis from prostate cancer
    Garcia, J. R.
    Franquet, E.
    Romera, N.
    Moragas, M.
    Jorcano, S.
    Moragas, G.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (01): : 56 - 57
  • [44] Prostate cancer patients with a single potentially treatable lesion at bone scintigraphy: 11C-choline PET/CT could have a role in the re-staging?
    Golemi, A.
    Fuccio, C.
    Santi, I.
    Castellucci, P.
    Maffione, A.
    Schiavina, R.
    Martorana, G.
    Lodi, F.
    Marengo, M.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S172 - S173
  • [45] Prostate Carcinoma: Diffusion-weighted Imaging as Potential Alternative to Conventional MR and 11C-Choline PET/CT for Detection of Bone Metastases
    Luboldt, Wolfgang
    Kuefer, Rainer
    Blumstein, Norbert
    Toussaint, Todd L.
    Kluge, Alexander
    Seemann, Marcus D.
    Luboldt, Hans-Joachim
    RADIOLOGY, 2008, 249 (03) : 1017 - 1025
  • [46] Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients
    Ghedini, P.
    Bossert, I.
    Graziani, T.
    Ceci, F.
    Massari, F.
    Nobili, E.
    Melotti, B.
    Castellucci, P.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S342 - S342
  • [47] Therapeutical changes in the management of patients with biochemical relapse of prostate cancer and positive 11C-Choline PET/CT
    Gomez-de la Fuente, F. J.
    Martinez-Rodriguez, I.
    Quince, R.
    De Arcocha-Torres, M.
    Lopez-Defillo, J. L.
    Jimenez-Alonso, M.
    Lucas-Velazquez, B.
    Tovar-Echeverri, D. F.
    Molina-Mendoza, G.
    Banzo, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S701 - S701
  • [48] Effectiveness of 11C-choline PET/CT in prostate cancer surveillance
    Martinez-Rodriguez, I.
    de Arcocha-Torres, M.
    Gomez de la Fuente, F. J.
    Jimenez-Bonilla, J.
    Sanchez-Salmoen, A.
    Martinez-Amador, N.
    Mendi-Barcina, V.
    Andres-Pacheco, J.
    Gutierrez-Gonzalez, A.
    Pombo-Lopez, M.
    Bota-Bota, A.
    Rodil-Gallego, M.
    Garcia-Ruiz, A.
    Quirce, R.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (02): : 93 - 99
  • [49] IMPACT OF 11C-CHOLINE PET/CT SCAN ON DETECTION OF RECURRENT PROSTATE CANCER IN MEN WITH BIOCHEMICAL RECURRENCE FOLLOWING FAILED INITIAL TREATMENT
    Mitchell, Christopher
    Kwon, Eugene
    Lowe, Val
    Hung, Joseph
    Rangel, Laureano
    Karnes, R. Jeffrey
    JOURNAL OF UROLOGY, 2012, 187 (04): : E823 - E823
  • [50] PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
    Fanti, Stefano
    Minozzi, Silvia
    Castellucci, Paolo
    Balduzzi, Sara
    Herrmann, Ken
    Krause, Bernd Joachim
    Oyen, Wim
    Chiti, Arturo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 55 - 69